Clonidine for Dogs: Uses, Dosing, and Safety

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-09-20

Clonidine is a centrally acting alpha-2 adrenergic agonist that veterinarians sometimes prescribe to dogs for sedation, anxiety-related behavior problems, and, less commonly, as an adjunct for blood pressure control or pain management. It is not FDA-approved for use in dogs, so any canine prescription is off-label and depends on a veterinarian's clinical judgment. Clonidine for dogs produces sedation, lowers heart rate, lowers blood pressure, and reduces sympathetic nervous system outflow. Those same effects are why it must be used carefully, especially in dogs with heart disease, low blood pressure, or dogs already receiving other sedatives.

This article is educational and is not a substitute for veterinary diagnosis or treatment.

At a Glance

What Clonidine Is and How It Works

Clonidine belongs to the alpha-2 adrenergic agonist family. These drugs bind alpha-2 receptors in the central nervous system and, to a lesser degree, in peripheral tissues. Activation of those receptors reduces the release of norepinephrine and lowers sympathetic outflow from the brain. The practical result in a dog is a calmer, more sedated patient with a slower heart rate and lower blood pressure.

The mechanism has been studied in dogs for decades. Early work showed that intravenous clonidine in conscious healthy dogs produced significant increases in plasma growth hormone within 15 minutes, with effects subsiding by 120 minutes. The alpha-adrenergic blocker phentolamine markedly attenuated those responses, confirming that the effect runs through alpha-adrenergic pathways [2]. A separate study in the nervous pointer dog, a genetic animal model of anxiety, found that oral clonidine at 100 micrograms/kg produced significant increases in plasma growth hormone compared with placebo, though the response did not differ between anxious and normal pointer dogs [3]. That work framed clonidine within the noradrenergic-hypothalamic axis that is relevant to fear and anxiety research.

Clonidine also produces antinociception, meaning it raises the threshold at which a dog responds to a painful stimulus. In conscious dogs, clonidine was 8 to 10 times more potent than two comparison alpha agonists at increasing nociceptive thresholds to mild electrical stimulation of the tooth pulp. At doses that produced equal antinociception, clonidine was the most sedating of the three compounds tested, and each drug produced dose-related bradycardia at antinociceptive doses [4]. Another study found that subcutaneous clonidine was 6 to 7 times more potent than morphine in several pain tests, and that clonidine's antinociception is predominantly centrally mediated [5].

The cardiovascular effects are the other half of the picture. Clonidine lowers blood pressure and heart rate through central sympathoinhibition. In dogs, this has been demonstrated repeatedly. When clonidine was given as a bolus of 2.0 micrograms/kg during baseline sedation with propofol or sevoflurane, cardiac output fell sharply and mucosal red cell flux dropped by 44 to 54 percent. Systemic perfusion recovered within about 30 minutes, but mucosal perfusion remained reduced [6]. That study is a reminder that the drug's effects are not uniform across all tissues and that the microcirculation can stay depressed even after cardiac output normalizes.

Why Clonidine Is Used Off-Label in Dogs

Clonidine is FDA-approved in humans for hypertension and attention deficit hyperactivity disorder, among other indications. No clonidine product carries an FDA-approved label for dogs. Every canine use is therefore off-label. Off-label prescribing is legal and common in veterinary medicine when a veterinarian determines that a drug is appropriate for a specific patient, but it means the dose, safety data, and monitoring plan come from published veterinary research and clinical experience rather than from a manufacturer's canine label.

The main off-label uses in dogs fall into three broad categories.

Sedation and pre-anesthetic calming

Clonidine produces reliable sedation in dogs. In a pharmacokinetic and pharmacodynamic study, oral clonidine at 0.05 mg/kg in healthy beagles produced mild sedation and slight reductions in heart rate, with no other adverse effects reported [1]. In an epidural infusion study, clonidine produced dose-dependent sedation along with lowered respiration rate, heart rate, and blood pressure, with maximum effects in the first one to three days of a 28-day infusion [7]. Sedation is a predictable, dose-related effect and is often the reason the drug is chosen.

Fear, anxiety, and behavior disorders

Clonidine has been described as well tolerated and useful in the treatment of canine fear-based disorders, though it is perceived to have a short duration of action [1]. The Merck Veterinary Manual lists clonidine among common drugs used to treat behavior problems in dogs [8]. Its role is usually as an adjunct to a broader behavior modification plan rather than a standalone fix. The short half-life means it may need to be timed around specific triggers, such as thunderstorms, fireworks, or veterinary visits, rather than given on a fixed daily schedule.

Adjunct for hypertension or analgesia

Clonidine's blood pressure lowering effect has been studied in dogs for decades. In conscious renal-hypertensive dogs, clonidine lowered blood pressure when given orally or intravenously, and it was equipotent with a comparison drug when administered into a lateral cerebral ventricle [9]. In anesthetized normotensive dogs, a related alpha-2 agonist produced a marked, prolonged fall in mean arterial pressure of about 20 mmHg, and splanchnic nerve discharges were strongly decreased, consistent with centrally mediated reduction of sympathetic tone [10]. Clonidine is also used as an adjuvant in regional anesthesia. In dogs, intrathecal and epidural clonidine produce dose-dependent antinociception, but the same doses produce hypotension and bradycardia that can limit usefulness [11]. A comparison study found that epidural clonidine had an ED50 of 51 micrograms for antinociception in dogs, while a newer agent was weaker epidurally [11]. Intrathecal clonidine at 250 micrograms per hour reduced heart rate by 45.8 percent, and five of six dogs developed bradyarrhythmias, which is a clear illustration of the cardiovascular ceiling on this use [12].

Dosing: What the Veterinary Literature Actually States

Dosing clonidine in dogs is not a matter of looking up a single number. The published doses vary widely by route, indication, and study design. The table below summarizes doses that appear in the approved veterinary literature. No dose in this article should be used without a veterinarian's direction.

Several points stand out. First, the oral dose of 0.05 mg/kg is the best-characterized canine dose in the modern literature, and it produced only mild sedation and bradycardia in healthy dogs [1]. Second, the intravenous doses used for growth hormone testing are far lower, in the 3 to 30 micrograms/kg range, and those doses produced minimal sedation and minimal effect on plasma glucose [2]. Third, the epidural and intrathecal doses are not comparable to oral dosing because they bypass the gastrointestinal tract and produce different plasma and tissue concentrations. Fourth, the duration of oral clonidine is short. In the pharmacokinetic study, plasma levels peaked 1.5 to 2 hours after dosing and fell below the limit of quantification 4 to 8 hours later, with an elimination half-life of about 0.65 hours [1]. That short half-life is why some clinicians describe clonidine as having a short duration of action and why redosing schedules matter.

A veterinarian choosing a dose will factor in the dog's weight, age, cardiac status, concurrent medications, and the specific goal. A dog being sedated for a thunderstorm is a different patient from a dog receiving clonidine as part of a chronic pain plan. There is no single correct dose, and the dose that appears in one study may not be the dose that suits an individual dog.

How Clonidine Is Given

Clonidine is most often given by mouth in dogs. The oral route is the least invasive and the easiest for owners to manage at home. Regular-release tablets are the formulation used in the canine pharmacokinetic study [1]. Extended-release formulations exist for human use, but canine pharmacokinetic and pharmacodynamic data on any clonidine formulation are limited, and the study that established the 0.05 mg/kg oral parameters used regular-release clonidine [1].

Clonidine can also be given intravenously in a hospital setting, and it can be delivered epidurally or intrathecally for regional anesthesia and pain management [11][12][7]. Those routes are not home options. They require a veterinarian, often a veterinary anesthesiologist or a specialist managing chronic pain.

A few practical points apply to oral dosing at home.

• Give the dose at the time your veterinarian specifies. Because the drug peaks in about 1.5 to 2 hours and clears within 4 to 8 hours, timing around a known trigger matters [1].
• Do not crush, split, or compound a tablet unless your veterinarian tells you to. Different formulations release the drug differently.
• Do not double up if you miss a dose. Call your veterinarian for instructions.
• Keep the medication out of reach of children and other pets.
• Store it as directed on the dispensing label.

Side Effects and What to Do About Them

The side effect profile of clonidine in dogs is dominated by its intended pharmacology. Sedation, bradycardia, and hypotension are not unexpected reactions. They are the drug working. The clinical question is whether the degree of effect is acceptable for the patient and the situation.

Sedation

Sedation is the most common effect. In the oral pharmacokinetic study, sedation scores increased in all treatment groups, and the effect was described as mild [1]. In the epidural infusion study, sedation increased dose-dependently and was maximum in the first one to three days [7]. In the intrathecal study, sedation or incoordination occurred only at the largest dose tested [12]. A sedated dog may be quieter, less responsive to surroundings, and sleepier than usual. Mild sedation is expected. Profound sedation, difficulty waking the dog, or inability to stand is not expected at standard doses and warrants a call to the veterinarian.

Bradycardia

Clonidine slows the heart rate. In the oral study, slight reductions in heart rate were seen in all treatment groups [1]. In the intrathecal study, clonidine at 250 micrograms per hour reduced heart rate by 45.8 percent, and five of six dogs had bradyarrhythmias [12]. In the epidural study, heart rate fell dose-dependently [7]. A slower heart rate is expected. A heart rate that is dramatically slow, irregular, or accompanied by weakness or collapse is an emergency.

Hypotension

Blood pressure falls with clonidine. In the epidural study, blood pressure was lowered dose-dependently [7]. In the intrathecal study, blood pressure was reduced with 125 to 500 micrograms per hour of clonidine [12]. In the bolus study, cardiac output fell from about 75 ml/kg/min to 40 to 49 ml/kg/min, with recovery to baseline after about 30 minutes, though mucosal perfusion stayed reduced [6]. A dog with low blood pressure may be weak, lethargic, or unsteady. If your dog seems weak or collapses after a clonidine dose, seek veterinary care immediately.

Respiratory effects

Respiration rate can decrease. In the epidural study, respiration rate fell dose-dependently and remained depressed even as other effects adapted over the 28-day infusion [7]. In the intrathecal study, respiratory rate decreased with 250 micrograms per hour of clonidine and larger doses [12]. A mildly reduced respiratory rate in a sedated dog is expected. Labored breathing, very slow breathing, or blue-tinged gums is an emergency.

Other effects

The oral pharmacokinetic study reported no adverse effects other than mild sedation and bradycardia [1]. The epidural toxicity study found no negative effects on body weight, body temperature, motor function, bowel or bladder function, or clinical pathology values over 28 days [7]. That is reassuring for short-term and medium-term use, but it does not mean clonidine is risk-free in every dog.

Rebound hypertension on abrupt withdrawal

Clonidine lowers blood pressure by reducing sympathetic outflow. When the drug is stopped suddenly, sympathetic outflow can rebound, and blood pressure can rise above the pretreatment level. This is a well-recognized effect of clonidine in human medicine and is a reason the drug is tapered rather than stopped abruptly. In dogs, the same principle applies. If your veterinarian has prescribed clonidine for blood pressure control or for a condition where sympathetic tone is a factor, do not stop the drug abruptly. Follow the tapering plan your veterinarian provides.

What to do if you see a problem

• Mild sleepiness and a slightly slower heart rate are expected. Note them and mention them at the next recheck.
• Profound sedation, inability to stand, collapse, very slow or irregular heartbeat, labored breathing, or blue gums are emergencies. Call your veterinarian or an emergency clinic immediately.
• If you suspect an overdose, call a veterinary poison control service or an emergency clinic. Do not wait for symptoms.
• Do not give another dose to "see if it helps." Do not give a stimulant or reversal agent on your own.

Indication, Adverse Effect, and Monitoring Table

Which Dogs Should Not Receive Clonidine

Clonidine is a cardiovascular drug as much as a behavior drug. The dogs most at risk are those whose hearts and blood vessels cannot tolerate a slower heart rate and lower blood pressure.

Dogs with pre-existing cardiac disease should not receive clonidine casually. The drug reduces heart rate and can provoke bradyarrhythmias, as seen when intrathecal clonidine at 250 micrograms per hour reduced heart rate by 45.8 percent and caused bradyarrhythmias in five of six dogs [12]. A dog with a conduction disorder, sick sinus syndrome, or significant valvular disease may not tolerate that.

Dogs with hypotension or conditions that predispose to low blood pressure should not receive clonidine without careful assessment. The drug lowers blood pressure dose-dependently [7] and reduces cardiac output acutely [6]. A dog already on the low side of normal is a poor candidate.

Dogs receiving other sedatives or cardiovascular drugs need special caution. Clonidine adds to the effects of other alpha-2 agonists, anesthetics, and sedatives. In the bolus study, clonidine was given on top of propofol or sevoflurane sedation and produced a sharp drop in cardiac output [6]. In the intrathecal study, sedation and incoordination occurred at the largest dose [12]. Combining clonidine with another sedative without adjusting doses is a recipe for excessive sedation and cardiovascular depression.

Dogs with hepatic or renal impairment may handle the drug differently. The pharmacokinetic study did not specifically evaluate these populations, so dose adjustment in organ dysfunction is a clinical judgment rather than a data-driven calculation [1].

Pregnant or nursing dogs, very young puppies, and dogs with known hypersensitivity to clonidine should not receive the drug unless a veterinarian has specifically determined that the benefit outweighs the risk.

Drug Interactions

Clonidine's interactions follow from its pharmacology.

• Other sedatives and anesthetics. Clonidine adds to central nervous system depression. The combination can produce deeper sedation than either drug alone. In dogs, clonidine given during propofol or sevoflurane sedation sharply reduced cardiac output [6].
• Other alpha-2 agonists. Drugs in the same class, such as dexmedetomidine and medetomidine, produce similar effects. Combining them compounds sedation, bradycardia, and hypotension.
• Antihypertensives and diuretics. Adding clonidine to a dog already on blood pressure medication can cause excessive hypotension.
• Beta blockers and calcium channel blockers. These drugs also slow heart rate and lower blood pressure. Combining them with clonidine can produce marked bradycardia.
• Tricyclic antidepressants and other behavior medications. Because clonidine affects noradrenergic signaling, combining it with drugs that alter the same pathways can change the response to either drug. The Merck Veterinary Manual lists clonidine alongside other behavior medications, and the choice among them is a clinical decision [8].
• Alpha-2 antagonists. Drugs such as yohimbine and atipamezole reverse alpha-2 agonist effects. Atipamezole reverses xylazine sedation in dogs, and the same receptor pharmacology applies to clonidine [13]. Reversal should be done by a veterinarian, not at home.

Always give your veterinarian a complete list of everything your dog receives, including prescriptions, over-the-counter products, and supplements.

How Clonidine Compares With Other Options

Clonidine is one of several drugs a veterinarian might consider for sedation or anxiety in dogs. The choice depends on the goal, the dog's health, and the duration of effect needed.

Alpha-2 agonists as a class share sedation and cardiovascular effects. In a comparison of alpha-adrenoceptor agonists in dogs, clonidine was 8 to 10 times more potent than two other agonists at raising nociceptive thresholds, and at equal antinociceptive doses, clonidine was the most sedating [4]. Dose-related bradycardia occurred with all three compounds at antinociceptive doses [4]. That study shows that clonidine sits at the more sedating, more cardiovascularly active end of the class.

Newer alpha-2 agonists have been developed with the goal of separating analgesia from cardiovascular and sedative side effects. One such compound did not induce hypotension in telemetered dogs, while both it and clonidine produced similar dose-dependent decreases in heart rate [14]. Another, fadolmidine, produced long-lasting antinociception without the hypotension seen with clonidine during intrathecal infusion [11]. These comparisons are useful for understanding why clonidine is not always the first choice for pain management, but they do not change the fact that clonidine remains a recognized option for sedation and behavior support [1][8].

For behavior problems, clonidine competes with other medications listed in the Merck Veterinary Manual's table of common drugs used to treat behavior problems in dogs [8]. The right choice depends on the specific diagnosis, the dog's medical history, and the owner's ability to give the medication on the needed schedule. Clonidine's short duration is both an advantage (it can be timed to a trigger) and a disadvantage (it may need to be given more than once, and the effect may wear off before the trigger ends) [1].

For sedation before procedures, clonidine is not the only option. Other protocols use different drug classes, and the choice is made by the veterinarian based on the procedure and the patient. A study of sedation protocols in dogs found that different combinations produce different degrees of sedation and different effects on heart rate and blood pressure, which is why pre-procedure sedation is individualized [15].

Questions to Ask Your Veterinarian

Before starting clonidine for your dog, ask these questions.

1. What is the specific diagnosis or problem we are treating with clonidine?
2. What dose are you prescribing, and what formulation should I use?
3. How often should I give it, and how do I time it around the problem behavior or procedure?
4. What side effects should I watch for, and which ones mean I should call you immediately?
5. Does my dog have any heart, blood pressure, liver, or kidney condition that makes clonidine risky?
6. What other medications or supplements is my dog taking, and do any of them interact with clonidine?
7. How long do you expect my dog to be on clonidine, and how will we taper it if we stop?
8. What is the plan if the first dose does not work well or causes too much sedation?
9. Should I have a blood pressure or heart rate check before starting and during treatment?
10. What should I do if I miss a dose or give too much?

Limitations and When to Contact a Veterinarian

This article summarizes published veterinary research and standard pharmacology. It cannot predict how an individual dog will respond to clonidine. Every dog has a different heart, different blood pressure, different concurrent conditions, and a different reason for needing the medication. A dose that is appropriate for one dog may be too high or too low for another.

Contact a veterinarian promptly if any of the following occur after a clonidine dose.

• Your dog cannot be woken or cannot stand.
• Your dog collapses or faints.
• Your dog's heart rate feels very slow, very fast, or irregular.
• Your dog's breathing becomes labored, very slow, or your dog's gums look blue or pale.
• Your dog vomits repeatedly or cannot keep water down.
• Your dog seems weak, unsteady, or disoriented beyond the expected sedation.
• You gave more than the prescribed dose.
• Your dog was started on a new medication or supplement that might interact with clonidine.
• Your dog's behavior problem is not improving or is getting worse.

Do not stop clonidine abruptly if your veterinarian prescribed it for blood pressure control or for a condition where rebound hypertension is a concern. Call your veterinarian for a tapering plan.

Frequently Asked Questions

Is clonidine FDA-approved for dogs?

No. Clonidine is not FDA-approved for dogs, and all canine use is off-label. Veterinarians can legally prescribe it off-label when they judge it appropriate for a specific patient.

What is clonidine used for in dogs?

Clonidine is used off-label for sedation, for fear and anxiety disorders, and sometimes as an adjunct for blood pressure control or pain management. It is also listed among common drugs used to treat behavior problems in dogs [8].

How fast does clonidine work in dogs?

After oral dosing at 0.05 mg/kg, clonidine reaches peak plasma concentration about 1.5 to 2 hours after administration [1]. The sedative effect follows the plasma concentration, so the dog typically becomes noticeably calmer within that window.

How long does clonidine last in a dog?

Plasma levels fall below the limit of quantification 4 to 8 hours after an oral dose, and the elimination half-life is about 0.65 hours [1]. The clinical effect is short, which is why some veterinarians describe clonidine as having a short duration of action.

What are the main side effects of clonidine in dogs?

The main side effects are sedation, bradycardia, and hypotension. Mild sedation and slight reductions in heart rate were seen in healthy dogs given 0.05 mg/kg orally [1]. Higher doses and injectable routes produce more marked cardiovascular effects [12][7].

Can clonidine be stopped suddenly?

Clonidine should not be stopped abruptly when it is being used for blood pressure control or a condition where sympathetic tone matters. Abrupt withdrawal can cause rebound hypertension. Follow your veterinarian's tapering plan.

Can clonidine be given with other sedatives?

Clonidine adds to the effects of other sedatives and anesthetics. In dogs, clonidine given during propofol or sevoflurane sedation sharply reduced cardiac output [6]. Combining clonidine with another sedative without veterinary guidance can cause excessive sedation and cardiovascular depression.

What should I do if my dog has a bad reaction to clonidine?

Call your veterinarian or an emergency clinic immediately if your dog collapses, cannot be woken, has very slow or irregular breathing, has a very slow or irregular heartbeat, or has blue or pale gums. Do not give another dose or try to reverse the drug at home.

Related Articles

• Anesthesia Machine Safety Checks for Laboratory Animal Use
• Prednisone for Dogs: Uses, Side Effects, and Safety Guidelines
• Pharmacotherapy in Avian Medicine
• Hypothyroidism in Dogs: Weight Gain, Lethargy and Thyroxine Dosing
• Can Cats Eat Valerian Root? Sedative Effect and Dosing
• Ferret Care: Insulinoma hypoglycemia diet and prednisone dosing
• Adequan for Dogs: Uses, Dosing, and Safety
• Credelio Quattro for Dogs: Uses, Dosing, and Safety
• Pepcid for Dogs: Dosage, Uses, and Safety Guide

Sources

1. Pharmacokinetics of Orally Administered Clonidine in Dogs.
2. Clonidine or xylazine as provocative tests for growth hormone secretion in the dog.
3. Growth hormone response to clonidine in the nervous pointer dog model of anxiety.
4. Alpha-adrenoceptor-mediated antinociception and sedation in the rat and dog.
5. Antinociceptive activity of clonidine in the mouse, rat and dog.
6. Clonidine elicits a long-term depression in mucosal red cell flux.
7. Pharmacology and toxicology of chronically infused epidural clonidine.HCl in dogs.
8. Table: Common Drugs Used to Treat Behavior Problems in Dogs-Merck Veterinary Manual
9. A new centrally acting antihypertensive (ICI 106270) which separates antihypertensive effects from sedation.
10. Pharmacological properties of (N-dicyclopropylmethyl) amino-2-oxazoline (S 3341), an alpha-2 adrenoceptor agonist.
11. Pharmacodynamics of intrathecal and epidural fadolmidine, an α(2)-adrenoceptor agonist, after bolus and infusion in dogs-comparison with clonidine.
12. Continuous intrathecal clonidine and tizanidine in conscious dogs: analgesic and hemodynamic effects.
13. Comparative Pharmacokinetics of Intranasal or Intramuscular Atipamezole in Unsedated Dogs and Efficacy for Reversal of Xylazine Sedation.
14. Advantageous safety profile of a dual selective alpha(2C) agonist/alpha(2A) antagonist antinociceptive agent.
15. Acepromazine does not enhance sedation or reduce propofol requirements when combined with dexmedetomidine in dogs.